Starting the Wegovy pill can feel confusing, especially when its instructions look far stricter than those for most oral medications.
Many people assume that taking a tablet is simple, yet with oral semaglutide, small details like timing, fasting, and water amount directly affect whether the medication works at all. This often leads to missed doses, poor absorption, and frustration when results do not match expectations.
This article explains how the Wegovy pill doses are increased, how the tablet should be taken, and how to switch safely between tablets and injections. Understanding these rules helps ensure the medication works as intended and reduces avoidable side effects.
The official Wegovy pill dosing schedule
Wegovy tablets come in four strengths:
-
- 1.5 mg
- 4 mg
- 9 mg
- 25 mg
Wegovy tablets are started at a low dose and increased gradually. This helps your body adjust and lowers the chance of side effects such as nausea.
Treatment usually begins with 1.5 mg once daily. The dose is increased about every 30 days until you reach 25 mg once daily, which is the highest approved dose. Some people may stay on lower doses longer if side effects occur. Your healthcare provider will adjust the schedule based on how well you tolerate the medication.
If you miss a dose, skip it and take your next dose the following day at your usual time. Do not take two tablets to make up for a missed dose.
|
Treatment Phase |
Time Period |
Tablet (Once Daily) |
| Starting phase |
Weeks 1-4 / Days 1-30 |
1.5 mg |
| Dose increase 1 |
Weeks 5-8 / Days 31-60 |
4 mg |
| Dose increase 2 |
Weeks 9-12 / Days 61-90 |
9 mg |
| Ongoing dose |
Weeks 13-16 / Day 91 onward |
25 mg |
How to take the Wegovy pill

The label instructions for Wegovy tablets are very specific. Following them closely helps reduce day-to-day variability in absorption. According to the prescribing information, you should do all of the following:
Those last two points are common places where people slip. Splitting or crushing is not just “off-label.” The label explicitly says not to split or crush, and that matters because oral semaglutide is formulated to work in a specific way in the stomach.
Why is the empty stomach rule so strict for oral semaglutide
The reason is the biology of oral peptide absorption.
Semaglutide is a fragile protein. If you swallow it on its own, stomach acid and digestive enzymes would destroy most of it before it ever reaches your bloodstream. Oral semaglutide is co-formulated with an absorption enhancer called SNAC, which supports uptake in the stomach under controlled conditions.
SNAC helps in four main ways:
-
- It briefly raises stomach pH right where the tablet dissolves. As the tablet breaks down, SNAC temporarily makes the surrounding stomach environment less acidic. This slows down the activation of pepsin, an enzyme that normally breaks down proteins. With less active pepsin, semaglutide is less likely to be destroyed.
-
- It keeps semaglutide in a usable form. Semaglutide molecules tend to clump together in acidic conditions. SNAC changes the local chemical environment so the molecules stay separated. This makes them easier for the body to absorb.
-
- It temporarily loosens stomach cell membranes. SNAC briefly interacts with the stomach lining and makes the cell membranes more flexible. This creates a short window where semaglutide can pass directly through the stomach wall and enter the bloodstream.
-
- Its effects are short-lived and reversible. SNAC does not permanently alter the stomach lining. Once it is absorbed and cleared, the stomach cells return to normal.
Why fasting and water amount matter
In a 2021 study, researchers wanted to understand how food, water amount, and fasting time affect how much oral semaglutide actually gets into the bloodstream. Participants took oral semaglutide once a day for 10 days.
They were placed into one of three groups:
-
- Fed group: Ate a meal 30 minutes before taking the tablet and used a full glass of water
- Extended fasting group: Fasted overnight and for 4 hours after taking the tablet
- Reference group: Fasted overnight and waited 30 minutes after the dose before eating, using less water
Another group of participants all fasted overnight, but used either a small or moderate amount of water and waited 15, 30, 60, or 120 minutes before eating.
Blood levels of semaglutide were measured repeatedly to see how much drug was absorbed.
Results showed that people who ate before taking the tablet had little to no detectable semaglutide in their blood. On the other hand, everyone who fasted had measurable drug levels. This shows that food almost completely prevents absorption.
Fasting after the dose also improved absorption. Waiting much longer before eating allowed roughly 40% more semaglutide to enter the bloodstream compared with the standard 30-minute wait.
Using smaller or larger amounts of water did not significantly change drug levels. As long as water volume stayed within a reasonable range, absorption was similar.
These findings led to current dosing instructions:
-
- Take the tablet on an empty stomach
- Use no more than 120 mL (4 oz) of water
- Wait at least 30 minutes before eating, drinking, or taking other oral medications
How much of the dose actually gets absorbed
Only a small portion of the Wegovy tablet actually enters the bloodstream. When taken by mouth, about 1 to 2% of the semaglutide dose is absorbed. After you take the tablet, the highest blood level is reached about one hour later.
This may sound low, but semaglutide is very potent, and its once-daily dosing and long half-life allow small absorbed amounts to build up over time. As a result, drug levels become steady after about 4 to 5 weeks of regular use.
For people with overweight or obesity who do not have type 2 diabetes, the overall semaglutide exposure from the 25 mg daily tablet is expected to be similar to that of the 2.4 mg once-weekly Wegovy injection. However, blood levels tend to vary more from person to person with the tablet than with the injection.
Can you cut or split the Wegovy pill in half?
No. You should not cut, split, or crush the Wegovy pill.
The Wegovy tablet is specially designed to dissolve in a specific way in the stomach. Cutting or splitting it can interfere with how the medication is absorbed, which may reduce its effectiveness or make absorption unpredictable. It can also disrupt the SNAC absorption enhancer that helps semaglutide enter the bloodstream.
If your current dose feels too strong or causes side effects, talk to your healthcare provider. They can adjust your dose or slow down the titration schedule rather than altering the tablet.
Switching between Wegovy injections and Wegovy tablets
It is possible to switch between Wegovy tablets and injections when done correctly.
-
- From injection to tablet – If you are using Wegovy 2.4 mg injections once weekly, stop the injections first. One week after your last injection, you may start Wegovy 25 mg tablets once daily.
-
- From tablet to injection – If you are taking Wegovy 25 mg tablets daily, you may start 2.4 mg once weekly Wegovy injections the day after stopping the tablets. If you have trouble tolerating the tablet, your provider may start you at 1.7 mg weekly instead.
For people with type 2 diabetes who need additional weight loss, switching from the tablet to a lower injection dose may also be considered, followed by gradual dose increases.
Taking Wegovy tablets with other oral medications
Wegovy slows how quickly the stomach empties. This can affect how some oral medications are absorbed.
Most commonly used medications are not meaningfully affected. However, people who take levothyroxine along with Wegovy tablets had about 33% higher thyroid hormone levels in blood tests. Because of this, closer monitoring or dose adjustments may be needed.
No significant changes were seen with many other medications, including:
-
- Omeprazole
- Lisinopril
- Warfarin (both S-warfarin and R-warfarin)
- Metformin
- Digoxin
- Ethinyl estradiol and levonorgestrel (components of oral birth control)
- Furosemide
- Rosuvastatin
Laboratory testing also shows that semaglutide is unlikely to interfere with liver enzymes or drug transport systems involved in medication metabolism. This further reduces the chance of drug-to-drug interactions.
Using Wegovy with insulin or diabetes medications
Wegovy can lower blood sugar. Because of this, taking it together with insulin or certain diabetes pills that increase insulin release, such as sulfonylureas, can raise the risk of low blood sugar.
Wegovy has not been fully studied in people who use insulin. If you take insulin or insulin-boosting medications, your healthcare provider may lower those doses when Wegovy is started to reduce the chance of hypoglycemia. Blood sugar levels may need closer monitoring during this time.
How long do Wegovy tablets stay in the body?
SNAC is absorbed and cleared quickly, usually within 4 to 6 hours. Semaglutide is eliminated slowly, with an average clearance of about 0.05 L per hour and a half-life of approximately one week. It can remain detectable in the bloodstream for 5 to 7 weeks after the final injectable or oral dose.
Bottom line
Wegovy tablets are designed to be taken once daily with a gradual dose increase to improve tolerance and reduce side effects. Because oral semaglutide depends on the SNAC absorption system, taking the tablet on an empty stomach, with limited water, and waiting at least 30 minutes before eating is essential.
The tablet should never be split or crushed, as this can interfere with absorption. Switching between tablets and injections is possible when done correctly under medical guidance. When used as directed and monitored by a healthcare provider, Wegovy tablets can provide a consistent and effective oral treatment option for obesity.
Related Articles
Frequently Asked Questions
Sources
Aroda, V. R., Blonde, L., & Pratley, R. E. (2022). A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes. Reviews in endocrine & metabolic disorders, 23(5), 979–994. https://doi.org/10.1007/s11154-022-09735-8
Bækdal, T. A., Breitschaft, A., Donsmark, M., Maarbjerg, S. J., Søndergaard, F. L., & Borregaard, J. (2021). Effect of various dosing conditions on the pharmacokinetics of oral semaglutide, a human Glucagon-Like peptide-1 analogue in a tablet formulation. Diabetes Therapy, 12(7), 1915–1927. https://doi.org/10.1007/s13300-021-01078-y
GLP-1 Pill Information | Wegovy® (semaglutide). (n.d.). https://www.wegovy.com/about-wegovy/the-wegovy-pill.html




